title: LAS 30451: a novel 5-HT3 antagonist.
authors.affiliation: Servicio de Oncología Médica, Hospital Universitario San Carlos, Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: R
authors.initials: R
authors.lastname: Rosell
authors.forename: V
authors.initials: V
authors.lastname: Guillem
authors.forename: E
authors.initials: E
authors.lastname: Díaz-Rubio
authors.forename: I
authors.initials: I
authors.lastname: Moreno
authors.forename: V
authors.initials: V
authors.lastname: Soriano
authors.forename: A
authors.initials: A
authors.lastname: Fernández
authors.forename: A
authors.initials: A
authors.lastname: Pérez
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001549:Benzamides / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001643:Bridged Bicyclo Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019086:Bridged Bicyclo Compounds, Heterocyclic; D006801:Humans; D008297:Male; D011985:Receptors, Serotonin / Q000187:drug effects; D012702:Serotonin Antagonists / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced
chemical_list: D000932:Antiemetics; D001549:Benzamides; D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; C078370:pancopride